References:
1. Monticone S, Losano I, Tetti M, Buffolo F, Veglio F, Mulatero P. Diagnostic approach to low-renin hypertension. Clin Endocrinol (Oxf) . 2018;89(4):385-396. doi:10.1111/cen.13741
2. White PC, Obeid J, Agarwal AK, Tannin GM, Nikkila H. Genetic analysis of 11 beta-hydroxysteroid dehydrogenase. Steroids . 1994;59(2):111-115. doi:10.1016/0039-128x(94)90086-8
3. Wilson RC, Dave-Sharma S, Wei JQ, et al. A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A . 1998;95(17):10200-10205. doi:10.1073/pnas.95.17.10200
4. Sahay M, Sahay R. Low renin hypertension. Indian J Endocrinol Metab . 2012;16(5):728. doi:10.4103/2230-8210.100665
5. Craigie E, Evans LC, Mullins JJ, Bailey MA. Failure to downregulate the epithelial sodium channel causes salt sensitivity in Hsd11b2 heterozygote mice. Hypertens (Dallas, Tex 1979) . 2012;60(3):684-690. doi:10.1161/HYPERTENSIONAHA.112.196410
6. Knops NBB, Monnens LA, Lenders JW, Levtchenko EN. Apparent Mineralocorticoid Excess: Time of Manifestation and Complications Despite Treatment. Pediatrics . 2011;127(6):e1610-e1614. doi:10.1542/peds.2010-1928
7. Palermo M, Quinkler M, Stewart PM. Apparent mineralocorticoid excess syndrome: an overview. Arq Bras Endocrinol Metabol . 2004;48(5):687-696. doi:10.1590/S0004-27302004000500015
8. Kamide K, Kokubo Y, Hanada H, et al. Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense/frameshift mutations. Hypertens Res . 2006;29(4):243-252. doi:10.1291/hypres.29.243
9. Morineau G, Sulmont V, Salomon R, et al. Apparent Mineralocorticoid Excess: Report of Six New Cases and Extensive Personal Experience.J Am Soc Nephrol . 2006;17(11):3176-3184. doi:10.1681/ASN.2006060570
10. Al-Harbi T, Al-Shaikh A. Apparent mineralocorticoid excess syndrome: report of one family with three affected children. J Pediatr Endocrinol Metab . 2012;25(11-12). doi:10.1515/jpem-2012-0113
11. Yau M, Azkawi HS Al, Haider S, et al. A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred. Ann N Y Acad Sci . 2016;1376(1):65-71. doi:10.1111/nyas.13162
12. Razzaghy-Azar M, Yau M, Khattab A, New MI. Apparent mineralocorticoid excess and the long term treatment of genetic hypertension. J Steroid Biochem Mol Biol . 2017;165:145-150. doi:10.1016/j.jsbmb.2016.02.014
13. Draper N, Stewart PM. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol . 2005;186(2):251-271. doi:10.1677/joe.1.06019